SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-106933
Filing Date
2024-12-09
Accepted
2024-12-09 16:12:56
Documents
14
Period of Report
2024-12-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0224119-8k_immucell.htm   iXBRL 8-K 28875
2 EMPLOYMENT AND SEPARATION AGREEMENT BETWEEN THE COMPANY AND ELIZABETH L. WILLIAM ea022411901ex10-1_immucell.htm EX-10.1 32775
  Complete submission text file 0001213900-24-106933.txt   243053

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE iccc-20241206.xsd EX-101.SCH 3015
4 XBRL LABEL FILE iccc-20241206_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE iccc-20241206_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0224119-8k_immucell_htm.xml XML 3567
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 241535247
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)